ProPhase Labs, Inc. (PRPH)

ProPhase Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	2.15	9.11	8.66	6.82	0.43
Short-Term Investments	3.13	8.33	8.86	1.64	0.93
Cash & Cash Equivalents	5.28	17.44	17.51	8.46	1.36
Cash Growth	-69.74%	-0.43%	107.13%	521.69%	-83.50%
Receivables	36.31	37.05	37.71	3.16	6.82
Inventory	3.84	3.98	4.6	3.04	1.46
Other Current Assets	2.16	2.37	1.5	1.24	0.3
Total Current Assets	47.59	60.83	61.32	15.89	9.95
Property, Plant & Equipment	17.47	11.35	10.35	8.31	2.33
Long-Term Investments	0	0	0	2.75	0
Goodwill and Intangibles	17.56	14.18	16.56	2.14	0
Other Long-Term Assets	9.31	1.28	1.07	2.32	0
Total Long-Term Assets	44.34	26.82	27.98	15.52	2.33
Total Assets	91.93	87.65	89.3	31.41	12.27
Accounts Payable	9.38	5.91	7.03	3.77	0.43
Deferred Revenue	3.48	3.56	2.94	0.33	0.11
Current Debt	2.79	0.3	0.66	0.33	0
Other Current Liabilities	5.2	6.31	4.9	1.86	0.39
Total Current Liabilities	20.86	16.08	15.52	6.29	0.93
Long-Term Debt	18.59	6.66	14.24	14.39	0
Other Long-Term Liabilities	3.1	1.28	0.91	0.16	0.11
Total Long-Term Liabilities	21.69	7.94	15.14	14.56	0.11
Total Liabilities	42.54	24.02	30.67	20.85	1.04
Total Debt	21.38	6.96	14.9	14.72	0
Debt Growth	207.18%	-53.29%	1.22%	-	-
Retained Earnings	-5.03	11.75	2.64	-3.63	-1.51
Comprehensive Income	-0.3	0.76	-0.18	-0.01	-0
Shareholders' Equity	49.38	63.63	58.63	10.56	11.23
Net Cash / Debt	-16.1	10.48	2.61	-6.27	1.36
Net Cash / Debt Growth	-	301.11%	-	-	-83.50%
Net Cash Per Share	-0.94	0.56	0.14	-0.54	0.12
Working Capital	26.73	44.76	45.79	9.59	9.01
Book Value Per Share	2.87	4.02	3.86	0.91	0.97

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).